Invitrogen Corporation Sets First Quarter Reporting Date and Conference Call For Thursday, April 26, 2001

Apr 17, 2001, 01:00 ET from Invitrogen Corporation

    SAN DIEGO, April 17 /PRNewswire/ -- Invitrogen Corporation (Nasdaq:   IVGN)
 will release its first quarter 2001 financial results on Thursday, April 26,
 2001 after the market closes.  Following the earnings release, the company
 will hold a conference call at 5:00 p.m. Eastern Standard Time to discuss its
 financial and business results for the first quarter of 2001 and to update its
 guidance for the full year.
     Lyle Turner, Invitrogen's Chairman and CEO, and James Glynn, Executive
 Vice President and CFO, will be the principal speakers on the call.  To listen
 to the conference call, please dial (973) 633-6740 after 4:50 pm EST.  A
 replay of the call will be available until May 12, 2001 by dialing
 (973) 341-3080 and using access code 2546606.
 
     About Invitrogen
     Invitrogen Corporation develops, manufactures and markets research tools
 in kit form and provides other research products and services to biotechnology
 and biopharmaceutical researchers and companies worldwide.  The company
 manufactures and markets thousands of products and services that simplify and
 improve gene cloning, gene expression, and gene analysis techniques for
 corporate, academic and government entities.  The company also engages in
 technology licensing, research services, large-scale production, and life
 science technical expertise and support.  Founded in 1987, Invitrogen is
 headquartered in San Diego, California and has operations in more than
 20 countries and distributor relationships in 40 more.  The company employs
 approximately 3,000 people at its worldwide locations.
 
     For more information about Invitrogen Corporation, please visit
 www.invitrogen.com.
 
 

SOURCE Invitrogen Corporation
    SAN DIEGO, April 17 /PRNewswire/ -- Invitrogen Corporation (Nasdaq:   IVGN)
 will release its first quarter 2001 financial results on Thursday, April 26,
 2001 after the market closes.  Following the earnings release, the company
 will hold a conference call at 5:00 p.m. Eastern Standard Time to discuss its
 financial and business results for the first quarter of 2001 and to update its
 guidance for the full year.
     Lyle Turner, Invitrogen's Chairman and CEO, and James Glynn, Executive
 Vice President and CFO, will be the principal speakers on the call.  To listen
 to the conference call, please dial (973) 633-6740 after 4:50 pm EST.  A
 replay of the call will be available until May 12, 2001 by dialing
 (973) 341-3080 and using access code 2546606.
 
     About Invitrogen
     Invitrogen Corporation develops, manufactures and markets research tools
 in kit form and provides other research products and services to biotechnology
 and biopharmaceutical researchers and companies worldwide.  The company
 manufactures and markets thousands of products and services that simplify and
 improve gene cloning, gene expression, and gene analysis techniques for
 corporate, academic and government entities.  The company also engages in
 technology licensing, research services, large-scale production, and life
 science technical expertise and support.  Founded in 1987, Invitrogen is
 headquartered in San Diego, California and has operations in more than
 20 countries and distributor relationships in 40 more.  The company employs
 approximately 3,000 people at its worldwide locations.
 
     For more information about Invitrogen Corporation, please visit
 www.invitrogen.com.
 
 SOURCE  Invitrogen Corporation